Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Intestinal surface" patented technology

Arabinoxylans for modulating the barrier function of the intestinal surface

The present invention is directed to a particular arabinoxylan (“AX”) preparation and the finding that this preparation has a beneficial effect on the organization of the intestinal microbial community in the lumen and in particular at the site of the gut mucosa, where it modulates the barrier function of the intestinal surface, primarily by modulating the mucosa-associated microbial community towards a relative increase of health beneficial bacteria, such as bifidobacteria and lactobacilli. It is accordingly a first aspect of the present invention to provide said arabinoxylan preparation characterized in comprising isolated water-soluble arabinoxylans and the use thereof to improve functioning (e.g. barrier function) of the intestinal epithelium. Thus, in a further aspect the present invention provides compositions, both pharmaceutical and nutritional compositions, comprising said arabinoxylan preparations; in particular pharmaceuticals, medical foods, food supplements or food compositions, such as infant formula products, dairy products, bakery products or pastry products. The compositions optionally comprise probiotics such as Bifidobacterium or Lactobacillus.
Owner:BIOACTOR

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; threonine is a component of mucoprotein; glutamine is a main energy source of intestinal mucosa. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of the goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma has efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of the goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

MG53 protein/MG53 mutant protein enteric capsule and preparation method thereof

The present invention provides an MG53 protein / MG53 mutant protein enteric capsule and a preparation method thereof, and belongs to the technical field of medicines. The MG53 protein / MG53 mutant protein enteric capsule comprises a MG53 protein / MG53 mutant protein enteric micro-pellet and a blank enteric capsule; the MG53 protein / MG53 mutant protein enteric micro-pellet comprises the following components: 25 parts by weight of freeze-dried powder of MG53 or MG53 mutant proteins, 100-120 parts by weight of pellet cores and 2-5 parts by weight of a binder; the enteric capsule micro-pellet has a moisture content of 1.5%-3%; and enteric coating weight gain is controlled at 25%-30%. The preparation method of the MG53 protein / MG53 mutant protein enteric capsule can ensure that the proteins do notdegrade, effectively ensure activity, avoid destruction of the MG53 proteins or MG53 mutant proteins by various proteases in digestive tract, delays to intestinal administration, enables distributionarea of medicines on intestinal surfaces to be increased, improves bioavailability of the medicines, and at the same time reduces stimulation of intestines.
Owner:MUDANJIANG YOUBO PHARMA CO LTD

Prescription for treating inflammatory bowel disease

The invention discloses a prescription for treating inflammatory bowel disease and belongs to the field of medicines. The prescription is prepared from lucid ganoderma, salvia miltiorrhiza, tuckahoe, glutamine, threonine, serine and cysteine; the lucid ganoderma, the salvia miltiorrhiza and the tuckahoe have effects of enhancing blood supply and oxygen supply of a human body; the glutamine is used as a main energy source of intestinal mucosa; the threonine, the serine and the cysteine are used as components of mucoprotein. The prescription disclosed by the invention provides nutrition, oxygen and raw materials for generation, renewal and repair of goblet cells and an intestinal surface mucous layer barrier formed by mucoprotein secreted by the goblet cells; the prescription has significant effects for terminating inflammation, repairing intestinal tissues and constructing a normal intestinal surface mucous layer barrier of the human body, and is an effective prescription for treating the inflammatory bowel disease.
Owner:何松庆

Eleventh formula for treating inflammatory bowel disease

The invention discloses an eleventh formula for treating inflammatory bowel disease, and belongs to the field of medicine. The formula comprises the components of salvia miltiorrhiza, threonine, vitamin C, vitamin E, vitamin A and beta-carotene. Salvia miltiorrhiza has the efficacies of enhancing human blood supply and oxygen supply; threonine is a constituent part of mucoproteins; vitamin C, vitamin E, vitamin A and beta-carotene have the effects of blocking and inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals and protecting human body cells. The formula provides nutrients, oxygen and raw materials for generation, updating and repairing of goblet cells and for goblet cell secreting of the mucoproteins to construct an intestinal surface mucous layer barrier. The formula has obvious effects on terminating inflammation, repairing intestinal tissues and building the human body normal intestinal surface mucus layer barrier, and is an effective formula for treating inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal tissue cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, radix salviae miltiorrhizae, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease and belongs to the field of medicines. The composition comprises the following components: salvia miltiorrhiza, glutamine, threonine, serine, cysteine, vitamins C, E and A, and beta-carotene. The salvia miltiorrhiza has the efficacy of enhancing blood supply and oxygen supply of human bodies; glutamine is a main energy source for the intestinal mucosa; threonine, serine and cysteine are main components of mucoprotein; the vitamins C, E and A and beta-carotene have the effects of inhibiting activity of oxygen free radicals, removing oxygen free radicals and protecting human cells. The composition disclosed by the invention provides nutrients, oxygen and raw materials for goblet cells for development, renewal and repairing as well as secretion of mucoprotein to form the intestinal surface mucous layer barrier. The composition has an obvious effect for termination of inflammation, repairing of intestinal tissue and establishment of the normal intestinal surface mucous layer barrier of a human body and is an effective composition for treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease and belongs to the field of medicines. The composition comprises the following components: ganoderma lucidum, salvia miltiorrhiza, ginseng and poria cocos. The ganoderma lucidum, salvia miltiorrhiza, ginseng and poria cocos have the efficacy of enhancing blood supply and oxygen supply of human bodies. The composition disclosed by the invention provides nutrients, oxygen and raw materials for goblet cells for development, renewal and repairing as well as secretion of mucoprotein to form the intestinal surface mucous layer barrier. The composition has an obvious effect for termination of inflammation, repairing of intestinal tissue and establishment of the normal intestinal surface mucous layer barrier of a human body and is an effective composition for treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating the inflammatory bowel disease, and belongs to the field of medicines. Intestinal epidermal goblet cells are reinforced to construct a normal intestinal surface mucus layer barrier in order to prevent intestinal antigens from approaching, contacting, adhering and entering intestine wall tissues, so abnormal immune response and inflammation generation are blocked out. Salvia miltiorrhiza has the efficacy of enhancing human body blood supply and oxygen supply; threonine is a composition part of mucoproteins, and is an essential amino acid in human bodies; and glutamine is the main energy source of intestinal mucosa. The composition provides nutrition, oxygen and raw materials for generation, updating and restoration of goblet cells and an intestinal tract surface mucus layer barrier composed of mucoproteins secreted by the goblet cells. The composition obtained through combining Salvia miltiorrhiza, ginseng and glutamine has obvious inflammation termination, intestinal tract tissue restoration and human body normal intestinal tract surface mucus layer barrier construction effects, and is an effective formula for treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ginseng, glutamine, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ginseng has efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises radix salviae miltiorrhizae, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein radix salviae miltiorrhizae has efficacies of strengthening blood supply and oxygen supply to the human body; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Formula for treating inflammatory bowel disease

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula of the invention follows the principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier and preventing intestine antigen from approaching, getting into contact with, adhering to and entering an intestinal wall tissue, so as to block abnormal immune response and the happening of inflammation. Radix salviae miltiorrhizae has functions of enhancing blood supply and oxygen supply of a human body; glutamine serves as a main energy source of intestinal mucosa; and threonine, serine and cysteine are main constituent parts of mucoprotein. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of the mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, threonine, glutamine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma has efficacies of strengthening blood supply and oxygen supply to the human body; threonine is a component of mucoprotein; glutamine is a main energy source of intestinal mucosa; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Formula for treating inflammatory bowel disease

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula consists of lucid ganoderma, radix salviae miltiorrhizae, ginseng, vitamin C, vitamin E, vitamin A and beta-carotene. The lucid ganoderma, the radix salviae miltiorrhizae and the ginseng have functions of enhancing blood supply and oxygen supply of a human body; and the vitamin C, the vitamin E, the vitamin A and the beta-carotene have functions of depressing the activity of oxygen radical, eliminating the oxygen radical and protecting body cells. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.
Owner:何松庆

A method for isolating primary dendritic cells of mouse intestinal lamina propria

The invention discloses a method for isolating primary dendritic cells of the intestinal lamina propria of mice. Including cutting the intestinal tube into 10‑12cm intestinal segments, washing out intestinal surface impurities and intestinal surface mucus, washing the intestinal epithelial cell layer with digestive solution B containing EDTA and EGTA, and then digesting with Liberase TL and DNase I solution C; finally sorted by flow cytometry to obtain the primary dendritic cells of the mouse intestinal lamina propria. The primary dendritic cells isolated by the method of the invention have high purity and complete phenotype characteristics.
Owner:NANJING DRUM TOWER HOSPITAL

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; threonine, serine and cysteine are components of mucoprotein. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of the goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Dietary supplement to promote gut health

Provided are dietary supplement composition comprising one or both of L-theanine and a trace mineral complex, optionally in combination with bioactive peptides, in an amount or amounts individually or in combination effective to promote gut health. Further optional components include a fiber oligosaccharide prebiotic, a polyphenol prebiotic, and a polynucleotide or blend. Examples of benefits include one or more of: —an increase in the amount of total short-chain fatty acid production or of at least one of propionate, acetate and butyrate; —an increase the expression or level of at least one tight junction protein (for example, claudin-1, claudin-3, claudin-4, occludin, or a zona occludens protein) or mucin-3 or decrease the expression or level of claudin-2; —an increase in transepithelial electrical resistance; —an increase in the abundance or diversity of a member or phylum of the intestinal bacterial community of the Intestinal lumen or mucus area (for example, Firmicutes, Bacteroidetes, Lactobacilli, Bifidobacteria, F. prausnitzii, or A. muciniphila); —an increase in the expression or level of at least one intestinal surface area marker protein (for example, villin, myosin, cadherin or sucrase-isomaltase). Methods for using such supplements are also disclosed.
Owner:TERRAGENICS NUTRITION INC

Formula for treating inflammatory bowel disease

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula consists of ginseng, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene. The ginseng has functions of enhancing blood supply and oxygen supply of a human body; the threonine, the serine and the cysteine are main constituent parts of mucoprotein; and the vitamin C, the vitamin E, the vitamin A and the beta-carotene have functions of depressing the activity of oxygen radical, eliminating the oxygen radical and protecting body cells. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of the mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.
Owner:何松庆

Prescription for treating inflammatory bowel disease

The invention discloses a prescription for treating inflammatory bowel disease and belongs to the field of medicines. The prescription is prepared from lucid ganoderma, salvia miltiorrhiza, tuckahoe, vitamin C, vitamin E, vitamin A and beat-carotene; the lucid ganoderma, the salvia miltiorrhiza and the tuckahoe have effects of enhancing blood supply and oxygen supply of a human body; the vitamin C, the vitamin E, the vitamin A and the beat-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals and protecting human body cells. The prescription disclosed by the invention provides nutrition, oxygen and raw materials for generation, renewal and repair of goblet cells and an intestinal surface mucous layer barrier formed by mucoprotein secreted by the goblet cells; the prescription has significant effects for terminating inflammation, repairing intestinal tissues and constructing a normal intestinal surface mucous layer barrier of the human body, and is an effective prescription for treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, poria cocos, glutamine, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma and poria cocos have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Formula for treating inflammatory bowel disease

The invention discloses a formula for treating inflammatory bowel disease, and belongs to the field of drugs. The formula of the invention follows the principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier and preventing intestine antigen from approaching, getting into contact with, adhering to and entering an intestinal wall tissue, so as to block abnormal immune response and the happening of inflammation. Radix salviae miltiorrhizae has functions of enhancing blood supply and oxygen supply of a human body; and glutamine serves as a main energy source of intestinal mucosa. The formula of the invention can provide nutrition, oxygen and raw materials for the generation, renewal and repair of goblet cells and for the secretion of mucoprotein from the goblet cells to form an intestinal surface mucous layer barrier. The formula of the invention, as an effective formula for treating inflammatory bowel disease, takes significant effects on terminating inflammation, repairing intestinal structure and building the normal intestinal surface mucous layer barrier of the human body.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, threonine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma has efficacies of strengthening blood supply and oxygen supply to the human body; threonine is a component of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises poria cocos, glutamine, threonine, serine, cysteine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein poria cocos has efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; threonine, serine and cysteine are components of mucoprotein; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of the goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆

Prescription for treating inflammatory bowel disease

The invention discloses a prescription for treating inflammatory bowel disease and belongs to the field of medicines. The prescription is prepared from lucid ganoderma, threonine, serine and cysteine, vitamin C, vitamin E, vitamin A and beat-carotene; the lucid ganoderma has effects of enhancing blood supply and oxygen supply of a human body; the threonine, the serine and the cysteine are used as main components of mucoprotein; the vitamin C, the vitamin E, the vitamin A and the beat-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals and protecting human body cells. The prescription disclosed by the invention provides nutrition, oxygen and raw materials for generation, renewal and repair of goblet cells and an intestinal surface mucous layer barrier formed by mucoprotein secreted by the goblet cells; the prescription has significant effects for terminating inflammation, repairing intestinal tissues and constructing a normal intestinal surface mucous layer barrier of the human body, and is an effective prescription for treating the inflammatory bowel disease.
Owner:何松庆

Composition for treating inflammatory bowel disease

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, radix salviae miltiorrhizae, ginseng, threonine, serine and cysteine, wherein ganoderma, radix salviae miltiorrhizae and ginseng have efficacies of strengthening blood supply and oxygen supply to the human body; threonine, serine and cysteine are components of mucoprotein. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.
Owner:何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products